John Nemunaitis

John is a co-founder and Chief Scientific Officer at Gradalis. He specializes in medical oncology and hematology and is board certified in internal medicine. He is an Oncologist and has been exploring therapies for cancer treatments for over 30 years.

Dr. Nemunaitis previously held academic positions at University of Toledo's Eleanor N. Dana Cancer Center, Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine. He is a member of the board of directors of the American Cancer Society of Gene and Cell Therapy and is on the editorial board of several peer reviewed journals focusing on cancer and molecular sciences. Dr. Nemunaitis has authored 444 peer-reviewed publications and 45 book chapters.